Eventide Asset Management, LLC Avrobio, Inc. Transaction History

Eventide Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$10.54 - $19.3 $13.8 Million - $25.2 Million	-1,305,307 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$12.79 - $17.1 $7.67 Million - $10.3 Million	-600,000 Reduced 31.49%	1,305,307 $18.2 Million
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $6.05 Million - $16.3 Million	600,000 Added 45.97%	1,905,307 $29.6 Million
Q3 2019 Nov 21, 2019	BUY	$14.12 - $23.44 $5.31 Million - $8.82 Million	376,416 Added 40.52%	1,305,307 $18.4 Million
Q2 2018 Aug 14, 2018	BUY	$28.08 - $31.2 $26.1 Million - $29 Million	928,891 New	928,891 $25.6 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.